A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples